Related Experiment Video
Updated: Jan 5, 2026

07:39
SA-β-Galactosidase-Based Screening Assay for the Identification of Senotherapeutic Drugs
Published on: June 28, 2019
25.0K
Biochemical screening
M I Evans1, J E O'Brien, E Dvorin
1Division of Reproductive Genetics, Hutzel Hospital/Wayne State University, Detroit, Michigan.
Current Opinion in Obstetrics & Gynecology
|October 1, 1994
Abstract:
The goal of screening both low and high risk obstetrics populations for chromosomally abnormal fetuses continues to be developed in many centers worldwide. Advances in the past year have been multifocal in their approach--neural tube detection, the development of new markers for aneuploidy, and attempts to move screening into the first trimester.

